The Clorox Company CLX

NYSE | Producer | Household and hygiene products
Follow The Clorox free Follow free

Email when the signal or risk changes · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Updated: 5 Nov 2026 Base analysis: 31 Jul 2026

The news check keeps the assessment current.

General analysis — not personal advice.

SELL Clear

Existing position should be reviewed given deteriorating fundamentals.

Lowered guidance, margin compression and higher leverage support the REDUCE signal.

Market sentiment Negative ↓
Trend: Declining

Investors are predominantly negative after the weak organic growth and increased integration costs.

Risk assessment High
Dilution: Low No share issuances reported, strong cash flows.
Jurisdiction: Low Primary operations in the US and developed markets.
Execution: High ERP disruptions and GOJO integration require continued focus.

SELL is the call. Negative is the market mood. High risk means a lot can go wrong.

Latest change
  • 5 Nov 2026 — Report shows strong sales growth but lowered full-year guidance following higher costs and margin pressure.

The full analysis is open. Follow the company free for the full change history — and email next time the picture changes.

Show all changes (2) — follow the company free
About the company

The Clorox Company manufactures and sells consumer products in cleaning, disinfection and personal care. The company has a broad portfolio including Clorox, Glad, Brita, Burt's Bees and the recently acquired Purell. Operations are in a mature phase with focus on margin stability and operational efficiency.

Sector: Household and hygiene products
Type: Producer
Next report (Q2)
3 Feb 2027
Catalysts
◐
Feb 2027
Q2 FY2027 report High
○
Q4 2026
GOJO integration update Medium
Bull case

Strong dividend and defensive brands provide some support if margins stabilize.

Bear case

High leverage, lowered outlook and integration risks limit upside over the medium term.

Why this signal

Lowered guidance, margin compression and higher leverage support the REDUCE signal.

Recent news
  • Q1 FY2027 results showed net sales of $1.91B (+33% YoY) and adjusted EPS of $1.55, well above estimates. However, the company lowered full-year guidance to the lower end of the $5.70–6.00 range due to higher input-cost inflation and margin pressure. GOJO integration drove much of the growth but long-term debt rose sharply.

Key figures

Revenue
FY 2027
USD 1.9B
Revenue TTM
TTM
USD 6.9B
EBITDA
TTM
USD 1.1B
Net income
FY 2027
USD 0.2B
Cash
Q1 2026
USD 1.2B
Total debt
Q1 2026
USD 4.5B
Gross margin
FY 2027
40.4%
Shares outstanding
2026-01-20
121M
EPS
FY 2027
USD 1.41
Exchange
NYSE
Type
Producer
Sector
Household and hygiene products
The Clorox Company CLX
The Clorox — this picture changes. Follow free
Follow The Clorox free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.